ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 102 filers reported holding ADURO BIOTECH INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,314,000 | +21.7% | 1,239,700 | +76.7% | 0.00% | +100.0% |
| Q2 2019 | $1,080,000 | -32.0% | 701,608 | +75.8% | 0.00% | -50.0% |
| Q1 2019 | $1,588,000 | +575.7% | 399,035 | +2009.3% | 0.00% | – |
| Q3 2016 | $235,000 | -71.4% | 18,918 | -73.9% | 0.00% | -100.0% |
| Q2 2016 | $821,000 | – | 72,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $12,438,000 | 0.72% |
| Rubric Capital Management LP | 1,629,321 | $3,959,000 | 0.37% |
| Burrage Capital Management LLC | 135,898 | $330,000 | 0.26% |
| Artal Group S.A. | 902,500 | $2,193,000 | 0.05% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,141,278 | $2,773,000 | 0.05% |
| Point72 Asset Management, L.P. | 2,050,000 | $4,982,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 567,181 | $1,378,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 34,241 | $83,000 | 0.01% |
| Renaissance Technologies | 4,384,010 | $10,653,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 802,749 | $1,951,000 | 0.01% |